What Is Minoxidil for Hair? How It Works and Side Effects

Minoxidil is a topical or oral medication that stimulates hair growth and slows hair loss, most commonly used for androgenetic alopecia (the pattern baldness that affects both men and women). It was originally developed as a blood pressure drug, and the hair-growing side effect was discovered accidentally, leading to a reformulated topical version that has been available over the counter since the late 1980s.¹ It remains one of only two FDA-approved medications for pattern hair loss, and the science behind how it works, who responds well, and what side effects to expect is more nuanced than most people realize.

How Minoxidil Promotes Hair Growth

Minoxidil works through several overlapping mechanisms, and researchers are still sorting out which ones matter most. The drug opens potassium channels in the smooth muscle lining blood vessel walls, which relaxes and widens those vessels. This increases blood flow around hair follicles, delivering more oxygen and nutrients to cells that are actively growing hair. Minoxidil also stimulates vascular endothelial growth factor (VEGF), a protein that promotes the formation of new blood vessels around the follicle.

But vasodilation alone doesn’t fully explain the effect. In animal studies, minoxidil shortens the resting phase of the hair cycle, pushing dormant follicles back into active growth sooner than they would otherwise.² It also appears to extend the growth phase itself and enlarge miniaturized follicles, turning the thin, wispy hairs typical of pattern baldness into thicker, more visible ones. The combined result is that more follicles are actively growing at any given time, and the hairs they produce are sturdier.

One critical detail: minoxidil itself isn’t the molecule that does the work. Your hair follicles contain an enzyme called sulfotransferase that converts minoxidil into its active form, minoxidil sulfate. That conversion step is what actually triggers the hair-growing effects.³ This enzyme plays a major role in determining whether minoxidil works for you at all.

Why Minoxidil Doesn’t Work for Everyone

If you’ve tried minoxidil and felt like it did nothing, you’re not imagining things. Response rates vary widely, and the reason traces back to that sulfotransferase enzyme. People differ dramatically in how much of it their follicles produce, and those with low enzyme activity simply don’t convert enough minoxidil into the active form to see results. Because you need to use the drug for roughly six months before you can reliably judge whether it’s working, researchers have looked for ways to predict responders earlier.⁴

A diagnostic test based on plucked hair follicles can measure sulfotransferase activity and predict treatment response with roughly 93% sensitivity and 83% specificity.⁵ That test isn’t widely available in standard dermatology practice yet, but it’s a meaningful advance over the current approach of just waiting months and hoping. There’s also some evidence that adding tretinoin (a retinoid) to a minoxidil regimen can upregulate sulfotransferase activity, potentially converting some non-responders into responders.³

What to Expect in the First Few Months

When you start minoxidil, the first thing that often happens is more hair loss, not less. This initial shedding catches many people off guard and leads some to quit before the drug has had a chance to work. What’s happening is that minoxidil is pushing resting follicles into the growth phase prematurely, which means the old, dormant hairs get kicked out to make way for new ones.² The shedding typically peaks during the first few weeks and subsides within a couple of months.

Visible improvement generally takes at least three to four months of consistent use, and the full effect isn’t apparent until around six months. The timeline matters because it means you can’t evaluate minoxidil after a month or two and conclude it’s not working. The six-month mark is when most clinical trials perform their primary assessments, and for good reason.

Topical Minoxidil Strength and Gender Differences

Topical minoxidil comes in two main concentrations: 2% and 5%. In men, the evidence clearly favors the higher strength. A 48-week trial found that 5% topical minoxidil significantly outperformed 2% in hair count, patient-rated scalp coverage, and investigator assessments, and the response showed up earlier with the higher dose.⁶ The trade-off was more scalp itching and irritation in the 5% group.

For women, the picture is less clear-cut. A similar 48-week trial found that 5% minoxidil beat placebo on all primary measures and was better than 2% on patient self-assessment, but the 5% group had higher rates of itching, irritation, and unwanted facial hair growth.⁷ A Cochrane systematic review pooling data from multiple trials found that 2% and 5% minoxidil produced no meaningful difference in total hair count increase in women, and the rate of adverse events was similar between the two concentrations.⁸ In practice, many dermatologists start women at 2% and move to 5% only if needed, partly to avoid the unwanted facial hair that is more bothersome for many female patients.

Oral Minoxidil as an Alternative

Low-dose oral minoxidil has gained popularity in recent years, mainly because some people find the topical version messy, irritating, or hard to stick with. The oral form skips the scalp entirely and delivers minoxidil through the bloodstream. A randomized trial comparing 5 mg of oral minoxidil to 5% topical minoxidil in men found that the oral form produced a greater percentage increase in terminal hair density at the crown (about 27% higher than the topical group) and was rated as superior by photographic assessment at the vertex, though the two groups didn’t differ significantly on the frontal scalp.⁹

A separate randomized trial, however, found that both oral and topical forms significantly improved hair diameter over six months, with no significant difference between groups. Photographic assessment in that study actually showed more consistent density improvement with the topical form, though the difference between groups again wasn’t statistically significant.¹⁰ In both studies, over 60% of patients in each group were satisfied with their treatment. The general takeaway is that oral minoxidil is roughly comparable to topical for most measures, with possible advantages at the crown in men. The drawback is a higher rate of body and facial hair growth: about half the men on oral minoxidil in one trial reported unwanted hair on the body or face.⁹

Scalp Irritation and Contact Dermatitis

The most common side effects of topical minoxidil are local: itching, redness, flaking, and a dry or burning sensation on the scalp. These affect a meaningful percentage of users and are the main reason people stop treatment. But the culprit isn’t always the minoxidil itself. Topical formulations use solvents like propylene glycol, butylene glycol, or ethanol to dissolve the drug and help it penetrate the skin, and these solvents cause irritation or allergic reactions more often than minoxidil does.¹¹

In patch testing studies, propylene glycol triggered a positive reaction at a higher rate than minoxidil itself.¹² If you’re experiencing scalp irritation, switching to a foam formulation (which typically doesn’t contain propylene glycol) or a different vehicle base may solve the problem without having to abandon minoxidil entirely. If the irritation persists with a propylene glycol-free version, you may be one of the smaller percentage of people who are sensitive to minoxidil itself, and oral minoxidil could be an option worth discussing with a dermatologist.

Unwanted Hair Growth Beyond the Scalp

One of the more annoying side effects, especially for women, is hair growth in places you didn’t apply it. Across clinical trials involving over 1,300 women, about 4% spontaneously reported unwanted facial hair, following a dose-related pattern where the 5% solution caused it more than the 2%, and the 2% more than placebo.¹³ A small number of users discontinued treatment because of it.

The mechanism behind this distant hair growth is somewhat mysterious. In case reports of generalized body hair growth from topical scalp application, researchers couldn’t detect minoxidil in the blood, suggesting the response is idiosyncratic rather than driven by the drug circulating systemically. Some people’s hair follicles may simply be more sensitive to the drug, even at remote body sites.¹⁴ The effect is dose-dependent and more common when users apply more than the recommended amount, so careful application matters. And with oral minoxidil, the rate is much higher since the drug reaches follicles everywhere: up to half of men on oral minoxidil reported extra body or facial hair in one trial.

Systemic Side Effects and Who Should Not Use It

Because minoxidil was originally a powerful blood pressure drug, the question of cardiovascular side effects comes up often. At the low doses used for hair loss, systemic absorption from topical application is minimal. Oral minoxidil carries more systemic risk, though low-dose oral regimens (typically 0.625 to 5 mg) use far less than the doses once prescribed for hypertension (up to 40 mg or more). At higher doses, minoxidil can cause fluid retention and an increased heart rate, and when used long-term for blood pressure, it has been associated with left ventricular changes.¹⁵ These concerns are less relevant at the low doses used for alopecia, but they haven’t disappeared entirely, which is why oral minoxidil for hair loss should be prescribed and monitored by a physician.

Contraindications for oral minoxidil include pericardial disease, uncontrolled high blood pressure, and pregnancy.¹⁶ Women who are pregnant or planning to become pregnant should avoid both oral and topical minoxidil.

Staying on Treatment and What Happens When You Stop

Minoxidil only works for as long as you use it. Once you stop, the follicles it was supporting gradually return to their previous state, and regrowth hairs fall out over the following months. This is one of the biggest frustrations people have with the drug, and it plays a major role in compliance problems. In a study of 400 patients with pattern hair loss, a striking 86% had discontinued minoxidil at some point. Experiencing side effects tripled the odds of quitting. On the other hand, patients who perceived improvement or stabilization were far more likely to keep going.¹⁷

The practical implication is that managing side effects proactively, whether by switching formulations to reduce scalp irritation or adjusting the dose, can make the difference between long-term use and abandoning treatment before it delivers meaningful results. If you’ve been on minoxidil for over a year and see benefit, the data suggest you’re much more likely to continue. The hardest stretch is the first several months, when you’re dealing with shedding, possible irritation, and no visible payoff yet.

Combining Minoxidil With Other Treatments

Minoxidil is often used alongside other hair loss interventions. The most common combination is minoxidil plus finasteride, an oral drug that blocks the hormone responsible for shrinking follicles in androgenetic alopecia. Because the two drugs work through completely different mechanisms, they can complement each other. A trial of 45 men found that combining 5% minoxidil with finasteride produced greater improvements in hair density and shaft diameter than minoxidil alone. Adding microneedling to that combination produced even further gains, though the additional benefit of microneedling over the two-drug combo didn’t reach statistical significance.¹⁸

Microneedling on its own has attracted attention as an adjunct because the tiny punctures it creates may improve minoxidil penetration and trigger wound-healing signals that stimulate follicle activity. It’s worth noting that these combination studies are generally small. Still, the direction of the evidence consistently favors combination approaches over minoxidil alone, and many dermatologists now recommend them for patients whose response to monotherapy is underwhelming.

The Rosemary Oil Question

If you’ve spent any time on social media looking for hair loss solutions, you’ve probably seen rosemary oil promoted as a “natural minoxidil.” One small randomized trial did compare rosemary oil to 2% minoxidil over six months and found no significant difference in hair count between the two groups. Both groups saw meaningful improvement by six months, and rosemary oil caused less scalp itching.¹⁹ That’s a genuinely interesting result, but it was a single trial with a modest number of participants comparing rosemary oil to the lower-strength minoxidil, not the 5% formulation most commonly used today. The evidence is too thin to call the two equivalent. Rosemary oil might work for mild cases and is certainly gentler on the scalp, but anyone with progressive hair loss would be gambling by choosing it over a treatment backed by dozens of controlled trials.

Off-Label Uses for Beard and Eyebrow Growth

Minoxidil has been adopted off-label by people looking to grow fuller beards and thicker eyebrows. A systematic review and meta-analysis of the evidence found that applying minoxidil to the face was more effective than placebo for both beard and eyebrow growth, with minimal side effects. A 16-week trial using 3% minoxidil for beards found significant improvements in hair count, photographic ratings, and patient self-assessment compared to placebo, while a separate trial found 2% minoxidil effective for eyebrow hypotrichosis.²⁰

One particularly interesting application is for transgender men (assigned female at birth) who are on hormone therapy but want to accelerate facial hair growth. A study found that topical minoxidil produced a significant increase in upper lip and chin hair scores over six months in this population, and it was the first controlled demonstration of minoxidil’s efficacy specifically for that use case.²¹ These off-label uses remain physician-guided, but the evidence is accumulating that minoxidil’s follicle-stimulating effects aren’t limited to the scalp.

Use in Children and Older Adults

Minoxidil is primarily studied and marketed for adults, but low-dose oral minoxidil has been explored for children with hair disorders including alopecia areata, loose anagen syndrome, and other conditions where topical options are limited. A systematic review found promising results in the pediatric population, with the most common side effect being unwanted body hair in about 12% of patients. No children in the low-dose group discontinued treatment because of adverse effects, and the review concluded that oral minoxidil at doses up to 2.5 mg per day appears safe for infants, children, and adolescents. The review was more cautious about moderate and high doses, noting that children on those regimens tended to have severe underlying conditions and showed more concerning side effect profiles.²²

At the other end of the age spectrum, a retrospective study of patients aged 65 and older on systemic minoxidil for hair loss found that only about one in five experienced any side effect, with body and facial hair growth being the most common. Adverse events were managed through dose adjustments, salt restriction, or leg elevation, and only two patients had to stop the drug entirely. No serious cardiovascular events were recorded.²³ These are small studies, and older adults with heart conditions or fluid-retention issues warrant closer monitoring, but the early safety data is reassuring for an age group that was often excluded from earlier hair loss trials.

1
PubMed Central. Minoxidil and its use in hair disorders: a review
2
British Journal of Dermatology. Minoxidil: mechanisms of action on hair growth
3
PubMed. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
4
PubMed Central. Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
5
PubMed. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia
6
PubMed. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
7
Journal of the American Academy of Dermatology. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
8
Cochrane Database of Systematic Reviews. Interventions for female pattern hair loss
9
JAMA Dermatology. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial
10
PubMed. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial
11
PubMed. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment
12
PubMed Central. Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation
13
PubMed. Hypertrichosis in females applying minoxidil topical solution and in normal controls
14
Actas Dermo-Sifiliográficas. Generalized Hypertrichosis Due to Topical Minoxidil
15
PubMed Central. Minoxidil: an underused vasodilator for resistant or severe hypertension
16
PubMed. Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
17
PubMed Central. Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
18
PubMed. Clinical efficacy of microneedle combined with 5% Minoxidil solution and finasteride in the treatment of androgenetic alopecia in males
19
PubMed. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial
20
PubMed Central. Topical minoxidil effectiveness in enhancing facial aesthetics: A systematic review and meta-analysis
21
PubMed Central. Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy
22
PubMed Central. Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
23
Hair Transplant Forum International. A Retrospective Study on the Safety of Systemic Minoxidil for Hair Loss in the Older Population